Search Results

Below are the search engine results of your query.

Showing 2431-2440 of 2550 results

TW EIA 7TH 10305 10307

TW EIA 107 11 108 01

Consent Order Addendum - Submission Pursuant to Paragraphs 1 and 2.a August 31, 2020

Please find enclosed the following documents being submitted by Chemours pursuant to paragraphs 1 and 2.a of the Addendum to Consent Order Paragraph 12

Consent Order Progress Report For Second Quarter 2020

Submissions to the State of North Carolina and Cape Fear River Watch

Cover Letter - Final Quarterly Report for Initial Characterization of PFAS in Process and Non-Process Wastewater and Stormwater – Chemours Fayetteville Works, Fayetteville, NC (12/2020)

On behalf of Chemours, please see the enclosed Final Quarterly Report for the Initial Characterization of PFAS in Process and Non-Process Wastewater and Stormwater at Fayetteville Works.

Fayetteville Works Emissions Cover Letter Feb 2021

99% Facility-Wide Reduction of GenX Compounds Emissions Pursuant to Consent Order Paragraph 8.c

Monthly Emissions Report Pursuant to Consent Order Paragraph 8 May 21, 2019

Pursuant to Paragraph 8.d of the Consent Order, please find enclosed the monthly emissions report for GenX Compounds from Fayetteville Works.

The Chemours Company Reaches Agreement with North Carolina DEQ and Cape Fear River Watch

The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, today announced an agreement with the State of North Carolina and the Cape Fear River Watch regarding emission control, remediation efforts, and ongoing health studies related to the company’s Fayetteville Works manufacturing site.

Inventory of Emissions of GenX Compounds (Per Consent Order, Paragraph 8a) June-19

Chemours Company - Fayetteville Works

Interim SEEP Remediation Operation and Maintenance Report #8

This Operations and Maintenance Report #8 (O&M Report #8) has been prepared to document the operations, maintenance, and performance of the flow-through cells at Seeps A, B, C, and D from March 1 through April 30, 2022.